-
Patients Discharged From Hospital Often Lack Sufficient Knowledge About Their Medications
Drug-safety Issue: Prescription Medication Noncompliance Due to Patient Misunderstanding In the August 2005 issue of Mayo Clinic Proceedings (Mayo Clin Proc 2005;80:991-994) a small study report suggests that poor communication with patients when being…
-
Ernst v. Merck Vioxx Trial: Massive Verdict for Plaintiff; Knock-out Punch for Merck?
Merck Vows to Fight All Comers Despite Texas Jury’s Condemnation of Vioxx to Tune of $253 Million On August 19, 2005 Merck & Co. was found negligent in the nation’s first Vioxx trial, Carol…
-
Abbott’s Weight-loss Drug Meridia Gets a Confidence Vote by FDA
FDA Denies Public Citizen’s Petition to Remove Meridia from Market The FDA has decided that the benefits of Abbott Laboratories’ prescription weight-loss drug Meridia continue to outweigh the drug’s risks for select obese…
-
Crawford & Co. Go on Tour: FDA Road Show Will Visit Miami, Boston, and Phoenix
"Vision 2006" Public Meetings to be Hosted by FDA Commissioner Lester Crawford According to news reports published August 16, 2005, Lester Crawford, the new head of the FDA, will be putting on a series…
-
Health Canada Not in Any Rush to Return Vioxx to Pharmacies
Expert Panel Finds That Vioxx is Safe Enough — But is it, Really? Health Canada is balking, so to speak, at the recommendation of an expert panel it appointed to consider the issue of…
-
Pfizer to Change Its Ways as Regards How the Company Promotes Its Drugs to Consumers
Pfizer Promises to Provide More Detail on Serious Side Effect Risks in DTC Advertisements Pfizer — the world’s largest pharmaceutical company and the biggest "direct to consumer" (DTC) advertiser of prescription drugs — is…
